{"id":"https://openalex.org/W7133226830","doi":"https://doi.org/10.1158/1535-7163.c.8332104","title":"Data from Macrophage-Engaging IgG4 Antibody Triggers Cytotoxicity against Integrin \u03b1v\u03b23+ Cancers","display_name":"Data from Macrophage-Engaging IgG4 Antibody Triggers Cytotoxicity against Integrin \u03b1v\u03b23+ Cancers","publication_year":2026,"publication_date":"2026-03-02","ids":{"openalex":"https://openalex.org/W7133226830","doi":"https://doi.org/10.1158/1535-7163.c.8332104"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.c.8332104","doi":"https://doi.org/10.1158/1535-7163.c.8332104","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.8332104","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1535-7163.c.8332104","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5122197852","display_name":"Joshua P. Reddy","orcid":"https://orcid.org/0009-0005-7211-0641","observed_orcids":["https://orcid.org/0009-0005-7211-0641"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joshua P. Reddy","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0005-7211-0641","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058233211","display_name":"Ziqi Yu","orcid":"https://orcid.org/0000-0002-4952-8899","observed_orcids":["https://orcid.org/0000-0002-4952-8899"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ziqi Yu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4952-8899","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079762910","display_name":"Ryan M. Shepard","orcid":"https://orcid.org/0000-0002-7488-369X","observed_orcids":["https://orcid.org/0000-0002-7488-369X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ryan M. Shepard","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7488-369X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036182229","display_name":"Tami Von Schalscha","orcid":"https://orcid.org/0009-0007-8348-6200","observed_orcids":["https://orcid.org/0009-0007-8348-6200"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tami Von Schalscha","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0007-8348-6200","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5119236997","display_name":"Rebecca A. Clague","orcid":"https://orcid.org/0009-0008-1152-1633","observed_orcids":["https://orcid.org/0009-0008-1152-1633"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rebecca A. Clague","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0008-1152-1633","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5119236996","display_name":"Beatriz P. Peixoto","orcid":"https://orcid.org/0009-0004-1513-5407","observed_orcids":["https://orcid.org/0009-0004-1513-5407"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Beatriz P. Peixoto","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0004-1513-5407","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113436543","display_name":"Stephen J. McCormack","orcid":"https://orcid.org/0009-0005-6344-9651","observed_orcids":["https://orcid.org/0009-0005-6344-9651"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen J. McCormack","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0005-6344-9651","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045174120","display_name":"Mark W. Onaitis","orcid":"https://orcid.org/0000-0003-0997-6563","observed_orcids":["https://orcid.org/0000-0003-0997-6563"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark W. Onaitis","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0997-6563","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030557212","display_name":"Sara M. Weis","orcid":"https://orcid.org/0009-0008-3137-4239","observed_orcids":["https://orcid.org/0009-0008-3137-4239"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sara M. Weis","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0008-3137-4239","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089796560","display_name":"David A. Cheresh","orcid":"https://orcid.org/0000-0002-7193-8595","observed_orcids":["https://orcid.org/0000-0002-7193-8595"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David A. Cheresh","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7193-8595","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5079170443","display_name":"Hiromi Inoue Wettersten","orcid":"https://orcid.org/0000-0001-7144-3122","observed_orcids":["https://orcid.org/0000-0001-7144-3122"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hiromi I. Wettersten","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7144-3122","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.6182000041007996,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.6182000041007996,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.2272000014781952,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10831","display_name":"Cell Adhesion Molecules Research","score":0.06849999725818634,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/integrin-alphavbeta3","display_name":"integrin \u03b1v\u03b23","score":0.9929999709129333},{"id":"https://openalex.org/keywords/igg4-antibodies","display_name":"IgG4 antibodies","score":0.8669999837875366},{"id":"https://openalex.org/keywords/tumor-associated-macrophages","display_name":"tumor-associated macrophages","score":0.9380000233650208},{"id":"https://openalex.org/keywords/cd64","display_name":"CD64","score":0.8410000205039978},{"id":"https://openalex.org/keywords/inducible-nitric-oxide-synthase","display_name":"inducible nitric oxide synthase","score":0.9580000042915344},{"id":"https://openalex.org/keywords/macrophage-mediated-cytotoxicity","display_name":"macrophage cytotoxicity","score":0.8069999814033508},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.7480000257492065},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.7850000262260437},{"id":"https://openalex.org/keywords/nk-cell-cytotoxicity","display_name":"NK cell cytotoxicity","score":0.5669999718666077},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.5360000133514404}],"concepts":[{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.7369999885559082},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6718999743461609},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5616999864578247},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.551800012588501},{"id":"https://openalex.org/C195687474","wikidata":"https://www.wikidata.org/wiki/Q409715","display_name":"Integrin","level":3,"score":0.4948999881744385},{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.48170000314712524},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4408000111579895},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.436599999666214},{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.42739999294281006},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4260999858379364},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.4120999872684479},{"id":"https://openalex.org/C2776447464","wikidata":"https://www.wikidata.org/wiki/Q17927763","display_name":"CD64","level":3,"score":0.36039999127388},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.35670000314712524},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.34929999709129333},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.34619998931884766},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.34540000557899475},{"id":"https://openalex.org/C115085202","wikidata":"https://www.wikidata.org/wiki/Q425665","display_name":"Immunotoxin","level":4,"score":0.30329999327659607},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.3005000054836273},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.2994999885559082},{"id":"https://openalex.org/C2779244956","wikidata":"https://www.wikidata.org/wiki/Q184204","display_name":"Macrophage","level":3,"score":0.29670000076293945},{"id":"https://openalex.org/C45121317","wikidata":"https://www.wikidata.org/wiki/Q4927287","display_name":"Blocking antibody","level":3,"score":0.2928999960422516},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2906999886035919},{"id":"https://openalex.org/C125823703","wikidata":"https://www.wikidata.org/wiki/Q1616930","display_name":"Fragment crystallizable region","level":3,"score":0.2531999945640564},{"id":"https://openalex.org/C2777092746","wikidata":"https://www.wikidata.org/wiki/Q5939625","display_name":"Humanized antibody","level":4,"score":0.25099998712539673}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.c.8332104","doi":"https://doi.org/10.1158/1535-7163.c.8332104","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.8332104","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.c.8332104","doi":"https://doi.org/10.1158/1535-7163.c.8332104","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.8332104","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4415129726","https://openalex.org/W4205893357","https://openalex.org/W4393071777","https://openalex.org/W2967125546","https://openalex.org/W4361845940","https://openalex.org/W7133187829","https://openalex.org/W7133245085","https://openalex.org/W7133207717","https://openalex.org/W2065452679","https://openalex.org/W4362357080"],"abstract_inverted_index":{"Abstract":[0],"Integrin":[1],"\u03b1v\u03b23,":[2,123],"absent":[3],"in":[4,23,171,224],"most":[5],"normal":[6],"cells,":[7],"has":[8],"emerged":[9],"as":[10],"both":[11],"a":[12,15,73,109,182,192],"marker":[13],"and":[14,20,55,147,210],"driver":[16],"of":[17,86,114,128,142,177],"tumor":[18,226],"stemness":[19],"drug":[21],"resistance":[22],"epithelial":[24,70],"cancers,":[25],"making":[26],"it":[27],"an":[28,130],"attractive":[29],"therapeutic":[30],"target.":[31],"The":[32],"humanized":[33],"IgG1":[34,161],"anti-\u03b1v\u03b23":[35,96,152],"antibody":[36,97],"etaracizumab":[37,115],"was":[38,60,166],"originally":[39],"developed":[40,108],"to":[41,98,174,221],"exploit":[42],"NK":[43],"cell\u2013mediated":[44],"cytotoxicity":[45,101],"against":[46],"\u03b1v\u03b23-positive":[47,69],"tumors.":[48],"However,":[49],"despite":[50],"its":[51,58,104,160],"favorable":[52],"safety":[53],"profile":[54],"clinical":[56],"efficacy,":[57],"impact":[59],"insufficient":[61],"for":[62,121,126,185,195,206],"further":[63],"development.":[64],"We":[65,107],"previously":[66],"discovered":[67],"that":[68,93,212],"tumors":[71,202],"exhibit":[72],"tumor-associated":[74],"macrophage":[75],"(TAM)\u2013rich":[76],"microenvironment":[77],"with":[78,118,144,159],"limited":[79],"NK-cell":[80],"infiltration,":[81],"potentially":[82],"limiting":[83],"the":[84,95],"effectiveness":[85],"etaracizumab.":[87],"In":[88,139],"this":[89,164,213],"study,":[90],"we":[91],"hypothesized":[92],"re-engineering":[94],"activate":[99],"TAM-mediated":[100],"would":[102],"enhance":[103],"antitumor":[105,156],"activity.":[106],"fully":[110],"human":[111],"IgG4":[112],"variant":[113],"(anti-\u03b1v\u03b23":[116],"G4)":[117],"identical":[119],"affinity":[120],"integrin":[122,200],"but":[124],"optimized":[125],"activation":[127,170],"CD64,":[129],"immune":[131,186],"effector":[132],"cell\u2013activating":[133],"receptor,":[134],"selectively":[135],"expressed":[136],"on":[137],"macrophages.":[138],"organotypic":[140],"cultures":[141],"patients":[143],"lung":[145,149],"cancer":[146,150,208],"mouse":[148],"xenografts,":[151],"G4":[153],"demonstrated":[154],"superior":[155],"activity":[157],"compared":[158],"counterpart.":[162],"Mechanistically,":[163],"enhancement":[165],"driven":[167],"by":[168,203],"CD64":[169],"TAMs,":[172],"leading":[173],"robust":[175],"upregulation":[176],"inducible":[178],"nitric":[179],"oxide":[180],"synthase,":[181],"pivotal":[183],"enzyme":[184],"effector\u2013mediated":[187],"cytotoxicity.":[188],"Our":[189],"findings":[190],"reveal":[191],"powerful":[193],"strategy":[194],"targeting":[196],"highly":[197],"aggressive,":[198],"drug-resistant":[199],"\u03b1v\u03b23\u2013positive":[201],"harnessing":[204],"TAMs":[205],"antibody-mediated":[207],"therapy":[209],"demonstrate":[211],"Fc":[214],"switch":[215],"approach":[216],"may":[217],"be":[218],"broadly":[219],"applicable":[220],"other":[222],"targets":[223],"TAM-enriched":[225],"microenvironments.":[227]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2026-03-03T00:00:00"}